Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis

被引：0
|
作者：
Laroni, A. [1 ,2 ]
Armentani, E. [1 ]
de Rosbo, N. K. [1 ]
Ivaldi, F. [1 ]
Marcenaro, E. [1 ]
Sivori, S. [1 ]
Gandhi, R. [3 ,4 ]
Weiner, H. L. [3 ,4 ]
Moretta, A. [1 ]
Mancardi, G. L. [1 ,2 ]
Uccelli, A. [1 ,2 ]
机构：
[1] Univ Genoa, Genoa, Italy
[2] IRCCS San Martino IST, Genoa, Italy
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O8.08
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [21] PROPAGATION OF LARGE NUMBERS OF T-CELLS COEXPRESSING THE NK-CELL MARKER CD56
    SCHMIDTWOLF, IGH
    LEFTEROVA, P
    JOHNSTON, V
    HUHN, D
    BLUME, KG
    NEGRIN, RS
    BLOOD, 1993, 82 (10) : A520 - A520
  • [22] CD56 is a functional immune receptor for aging T cells
    Montag, D. T.
    Lemster, B. H.
    Michel, J. J.
    Koeske, Z.
    Studenski, S. A.
    Vallejo, A. N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S159 - S159
  • [23] Multiple Sclerosis and Regulatory T Cells
    Cristina Maria Costantino
    Clare Baecher-Allan
    David A. Hafler
    Journal of Clinical Immunology, 2008, 28 : 697 - 706
  • [24] Multiple Sclerosis and Regulatory T Cells
    Costantino, Cristina Maria
    Baecher-Allan, Clare
    Hafler, David A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2008, 28 (06) : 697 - 706
  • [25] Regulatory T Cells in Multiple Sclerosis
    Goverman, Joan M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (06): : 578 - 580
  • [26] CD56(+BRIGHT) BUT NOT CD56(+DIM) NATURAL-KILLER-CELL (NK), SUBSETS EXHIBIT CONTACT-MEDIATED PROLIFERATION
    PIERSON, BA
    MCGLAVE, PB
    HU, WS
    MILLER, JS
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 836 - 836
  • [27] Autoreactive Regulatory CD8+ T Cells in Multiple Sclerosis
    Baughman, Ethan
    Mendoza, Jason
    Frohman, Elliot
    Karandikar, Nitin
    CLINICAL IMMUNOLOGY, 2010, 135 : S44 - S45
  • [28] Exposure-response analyses of CD56bright NK cell expansion and regulatory T-cells reduction by daclizumab high-yield process (HYP) in subjects with multiple sclerosis
    Diao, L.
    Hang, Y.
    Othman, A. A.
    Mehta, D.
    Amaravadi, L.
    Nestorov, I.
    Tran, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 441 - 441
  • [29] Interferon-beta and regulatory cells: evaluation of treatment-induced modulation of Treg, Breg and CD56bright NK cell levels in multiple sclerosis patients
    Martire, S.
    Spadaro, M.
    Perga, S.
    Montarolo, F.
    Bertolotto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 598 - 598
  • [30] CD56bright natural killer (NK) cells: an important NK cell subset
    Poli, Aurelie
    Michel, Tatiana
    Theresine, Maud
    Andres, Emmanuel
    Hentges, Francois
    Zimmer, Jacques
    IMMUNOLOGY, 2009, 126 (04) : 458 - 465
12345